Egypt

Ranbaxy Egypt Limited, a subsidiary of Sun Pharmaceutical Industries Ltd, has been serving the Egyptian pharmaceutical market for over 29 years, with a strong commitment to quality, innovation, and patient care.

Our EDA-GMP approved manufacturing facility in Cairo is equipped with modern infrastructure to produce high-quality oral solid dosage forms.

We have built a robust sales, marketing, and distribution network, ensuring our products reach healthcare providers and patients across Egypt efficiently and reliably.

With presence across multiple therapeutic areas, we are proud to offer a portfolio of trusted and well-recognized brands, including Isotretinoin, Infectomycin, Oframax, Rancif, Joviapram, Sunseize, Quetiasu, Zesperone, and Serlift.

As part of Sun Pharma, one of the leading global specialty generic pharmaceutical companies in the world, we bring global expertise with a strong local presence — committed to improving health outcomes for patients in Egypt.